Regentis Biomaterials RGNT Cash Flow Statement (2024-2026)

NYSE RGNT
$1.51 +0.04 (+2.72%)
As of: Oct 21, 2026 · 11:11 AM EDT
Reported Financials

Regentis Biomaterials Quarterly Cash Flow Statement

Periods 3 quarters
Latest Jun 2026

Regentis Biomaterials cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Dec2025 Jun2026
Additional items
Ending Cash Balance 0.23M7.38M8.95M

Regentis Biomaterials Cash Flow Statement API

Pull Regentis Biomaterials's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY